Endo Investors

Endo makes investments in game-changing early-stage companies improving outcomes for large patient populations affected by various chronic diseases. Endo is backed by a group of mission-oriented investors and was created in response to a deficit of early-stage capital focused on companies impacting diabetes and other major global health issues.

Eric Edidin formed Endo Investors in 2013, soon after his then-toddler daughter was diagnosed with type-1 diabetes. Endo portfolio companies have made numerous cutting-edge breakthroughs for the patient populations they serve while simultaneously focusing on strong investor returns.

Mr. Edidin is also president of Three B Holdings, a private family investment company, Executive Chairman of BH3 Management, a real estate investment firm, and co-founded Archer Capital Management, an institutional asset management firm. Previously, he was a portfolio manager and co-head of credit investments at York Capital Management, a member of Morgan Stanley Capital Partners’ global private equity investment team, and Blackstone Group’s restructuring advisory team.

Mr. Edidin was formerly an executive board member of the JDRF of Los Angeles and a member of the investment committee of the Jewish Communal Fund of NY and the Jewish Federation of Los Angeles. Mr. Edidin currently serves as a board member of ELNET US and Chairman of ELNET- Central and Eastern Europe.

Eric holds a B.B.A. degree with the highest distinction from the University of Michigan, and an M.B.A from Harvard Business School and lives in Southern Florida with his wife and three children.